Loading company…
Opsonix, Inc. develops pathogen-extracting therapies for sepsis and other blood-borne infectious diseases.
Based in Cambridge, US, Opsonix, Inc. develops pathogen-extracting therapies for the treatment of sepsis and other blood-borne infectious diseases. The company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in